Murine AIDS, a key to understanding retrovirus-induced immunodeficiency

Viral Immunology

Volumn 9, Issue 4, 1996, Pages 225-239

  Liang, Bailin ^a,b   Wang, James Y ^c   Watson, Ronald R ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; DISEASE RESISTANCE; HYPERGAMMAGLOBULINEMIA; LYMPHADENOPATHY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; OXIDATIVE STRESS; RETROVIRUS; SPLENOMEGALY; T LYMPHOCYTE;

EID: 0030469214     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.225     Document Type: Article

References (122)

1. Acha-Orbea, H. et al. 1991. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature, 350:207.
2. Akama, H., Y. Ichikawa, Y. Matsushita, T. Shinozawa, and M. Homma. 1990. Mononuclear cells enhance prostaglandin E2 production of polymorphonuclesar leukocytes via tumor necrosis factor alpha. Biochem. & Biophys. Res. Comm. 168:857-862.
3. Akira, S., and T. Kishimoto. 1992. IL-6 and NF-IL6 in Acute-phase response and viral infection. Immunol. Rev. 127:25-50.
4. Alak, J.I.B., M. Shahbazian, D.S. Huang, Y. Wang, H. Darban, E.M. Jenkins, R.R. Watson. Suppression by dietary alcohol of resistance to Cryptosporidium during murine acquired immune deficiency syndrome. Adv. Experi. Med. Biol. 355:175-9, 1993.
5. Aldrovandl, G.M., G. Feuer, I. Gao, B. Jamleson, M. Kristeva, I.S.Y. Chen, and J.A. Zack. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature 363:732-736.
6. Amadori, A., et al. 1989. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HTV-1 infection. J. Immunol. 143:2146.
7. Amadori, A., and L. Cjieco-Bianchi. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol. Today 11:374.
8. Aziz, D.C., Z. Hunna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature 338:505-508.
9. Baccala, R., D.H. Kono, S. Walker, R.S. Balderas, and A.N. Theofilopoulos. 1991. Genomically imposed and somatically modified human thymocyte V beta gene repertoires. Proc. Natl. Acad. Sci. (USA) 88:2908.
10. Balkwill, F.R., and F. Burke. 1989. The cytokine network. Immunol. Today 10:299-304.
11. Baruchel, S., and M.A. Wainberg. 1992. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J. Leuk. Biol. 52:111-114.
12. Bergeron, L., J. Sullivan, and J. Sodroski. 1992. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66:2389.
13. Berkelmen, R.L., W.L. Heyward, J.K. Stehr-Green, and J.W. Curran. 1989. Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome. Am. J. Med. 86:761-766.
14. Beutler, B., and A. Cerami. 1988. Cachectin: More than a tumor necrosis factor. New Engl. J. Med. 316:379.
15. Bonyhadl, M.L., I. Rabin, S. Sallml, D.A. Brown, J. Kosek, J.M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature 363:728-732.
16. Boue, F., C. Wallon, F. Goujard, I. Barre-Sinoussi, and J.F. Defraissy. 1992. HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J. Immunol. 148:3761-3787.
17. Bradley, W.G., N. Ogata, R.A. Good, N.K. Day. 1994. Alteration of in vivo cytokine gene expression in mice infected with a molecular clone of the defective MAIDS virus. J. AIDS 7:1.
18. Breen, E.C., A.R. Rezai, T. Hirano, T. Kishimoto, and O. Martines-Maza. 1990. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:480-484.
19. Buhl, R., H.A. Haffe, and K.J. Holroyd. 1989. Systemic glutathione deficiency in sympton-free HIV-seropositive individuals. Lancet, 2:1294-1298.
20. Buller, R.M.L., R. A. Yetter, T.N. Fredrickson, and H.C. Morse III. 1987. Abrogation of resistance to severe mouse-pox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61:383-387.
21. Carding, S.R., A.C. Hayday, and K. Bottomly. 1991. Cytokines in T-cell development. Immunol. Today 12:239-245.
22. Ceredig, R., J. Medveczky, and A. Skulimowski. 1989. Mouse fetal thymus lobes cultured in IL-2 generate CD3+, TCR-gamma delta-expressing CD4+/CD8+ and CD4-/CD8- cells. J. Immunol. 144:4560-4566.
23. Cerny, A., A.W. Hugin, R.R. Hardy, K. Hayakawa, R.M. Zinkernagel, M. Makino, and H.C. Morse III. 1990. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:315-320.
24. Chattopadhyay, S.K., H.C. Morse III, M. Makino, S.K. Rusceti, H.W. Hartley. 1989. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome, MAIDS. Proc. Natl. Acad. Sci. (USA) 86:3862-3866.
25. Chattopadhyay, S.K., M. Makino, J.W. Hartley, and H.C. Morse III. 1989. In Immunodeficient Animals in Experimental Medicine, pp. 12-18. 6th Int. Workshop on Immune-Deficient Animals, Beijing. Basel, Karger.
26. Cheung, S.C., S.K. Chattopadhyay, J.W. Hartley, H.C. Morse III, and P.M. Pitha. 1991. Expression of defective virus and cytokine genes in murine AIDS. J. Virol. 65:3611-3616.
27. Cheung, S.C., S.K. Chattopadehyay, H.C. Morse III, and P.M. Pitha. 1991. Expression of defective virus and cytokine genes in murine AIDS. J. Virol. 65:823-828.
28. Choi, Y., J.W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 350:207.
29. Choi, Y.W., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. (USA) 86:8941.
30. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Sherer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759-765.
31. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107.
32. Cohon, J. 1993. T cell shift: Key to AIDS therapy? [news; comment]. Science 262:175-176.
33. Darban, H., J. Enriquez, C.R. Sterling, M.C. Lopez, G. Chen, and R.L. Watson. 1991. Modification of resistance of Streptococcus pneumonia by dietary alcohol, immunization and murine retroviral infection. Alcohol Clin. Exp. Res. Carcinogenesis 164:741-745.
34. Eck, H.P., H. Gmunder, M. Hartmann, S. Petzoldt, V. Daniel, and W. Droge. 1989. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe-Seyler 370:101-108.
35. Embertson, J., M. Zupancic, J.L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A.T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
36. Emilie, D., J. Coumbaras, M. Raphael, O. Devergne, H.J. Delecluse, C. Gisselbrecht, J.F. Michiels, J. Van Damme, J.T. Taga, T. Kishimoto, M.C. Crevon, and P. Galanaud. 1992. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 80:498-504.
37. Emilie, D., R. Touitou, M. Raphael, M. Peuchmaur, O. Devergne and D. Rea, J. Coumbraras, M.C. Crevon, I. Edelman, and I. Joab, P. Galanaud. 1992. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur. J. Immunol. 22:2937-2942.
38. Falloon, J., and H. Masur. 1992. Infectious complications of HIV Pneumocystis carinii and other protozoa. Pp. 157-167. In AIDS: Etiology, Diagnosis, Treatment, and prevention, (ed3), (Eds. Devita, V.T. Jr., S. Hellman, and S.A. Rosenberg) JB Lippincott Co., Philadelphia.
39. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
40. Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617-622.
41. Fitzpatrick, E.A., J.S. Bryson, C. Rhoads, A.M. Kaplan, and D.A. Cohen. 1992. T-deficient transmembrane signaling in CD4+ T-cells of retroviral-induced immune-deficient mice. J. Immunol. 148:3377-3384.
42. Floyd, R.A., and J.E. Schneider. 1989. In Membrane lipid oxidation Vol. I. Pp. 237-245. (Vigo-Pelfrey, C., Ed.) CRC Press. Boca Raton, FL.
43. Friedland, G., and R. Klein. Tuberculosis and other bacterial infections. Pp. 180-193. In AIDS: Etiology, Diagnosis, Treatment, and prevention, ed3, (Eds. Devita, V.T. Jr, S. Hellman, and Rosenberg S.A.) JB Lippincott Co., Philadelphia.
44. Gardner, M.B. 1990. In "Animal Models of AIDS" Pp. 279-290.
45. Gazzinelli, R.T., M. Makino, S.K. Chattopadhyay, C.M. Sanpper, A. Sher, A.W. Hugin, and H.C. Morse II. 1992. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148:182.
46. Giulian, D., K. Vaca, and C.A. Noonan. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593.
47. Greenberg, P. 1992. Immunopathogenesis of HIV infection. Hospital Practice 75-90.
48. Gutierrez-Ramos, J.C., A.C. Martenez, G. Kohler, and A. Iglesias. 1990. Analysis of T-cell subpopulations in human IL-2R alpha transgenic mice: expansion of Thy1.2- thymocytes and depletion of double-positive T-cell precursors. Immunol. Res. 140:661-674.
49. Halliwell, B., J.M. Gutterbridge. 1985. The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 8:189-193.
50. Herman, A., G. Groteau, R.R. Sekaly, J.W. Kappler, and P. Marrack. 1990. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med. 172:709.
51. + T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur. J. Immunol. 20:2783-2787.
52. Huang, D.S. 1993. Ph.D. Dissertation. Immunological changes in retrovirus-infected mice. University of Arizona, Tucson, Arizona, U.S.A.
53. Huang, M., C. Simard, P. Jolicoeur. 1989. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science 246:1614-1617.
54. Huang, D.S., Y. Wang, J.J. Machilonis, and R.R. Watson. 1993. Kinetics of cytokine production and proliferation in mesenteric lymph nodes during the progression of LP-BM5 murine leukemia virus infection. Regional Immunol. 5:325-331.
55. Hugin, A.W., M.S. Vacchio, and H.C. Morse III. 1991. A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424-427.
56. Imberti, L., A. Sottini, A. Bettinardi, M. Puoti, and D. Primi. 1991. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254:860-862.
57. Janeway C. 1991. Immune recognition. MIS:makes a little sense. Nature 349:459.
58. Johnson, K.J., J.C. Fantone, J. Kaplan, and P.A. Ward. 1981. In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest. 67:983-993.
59. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study AIDS pathogenesis. FASEB. J. 5:2398-2405.
60. Jolicoeur, P., Z. Hanna, D. Aziz, C. Simard, and M. Hunag. 1991. In Viruses that affect the immune system (Eds. Fan, P., Chen, I. Rosenberg, N., and Sugden, W.) American Society for Microbiology (1991).
61. Josh, V.V., and J.M. Oleske. 1985. Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. Arch. Pathol. Lab. Med. 109:142-146.
62. Kalebc, T., A. Kinter, G. Poli, M.E. Anderson, A. Mester, and A.S. Fauci. 1990. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc. Natl. Acad. Sci. (USA) 88:986-990.
63. Katz, I.R., S.E. Krown, B. Safai, H.F. Oettgen, and M.K. Hoffman. 1986. Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome. Clin. Immunol. Immunopath. 39:359.
64. Klinman, D.M., and H.C. Morse III. 1993. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1144-1149.
65. Klebanoff, S.J., M.A. Vadas, and J.M. Harlan. 1987. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:4220-4225.
66. Lahdevirta, K., C.P.L. Maury, A.M. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289-291.
67. Lahdevirta, J., C.P.J. Maury, A.M. Teppo, and H. Repo. 1986. Elevated level of circulating cachectin, tumor necrosis alpha in patients with acquired immunodeficiency syndrome. Am. J. Med. 172:151-156.
68. Lane, H.C. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:355.
69. Latarjet, R., and J.F. Duplan. 1962. Experiment and discussion on leukaengenesis by cell-free extracts of radiation-induced leukaemia in mice. Int. J. Radiat. Biol. 5:339-344.
70. Lesley, J., J. Trotter, A. Schutle, and R. Hyman. 1990. Phenotypic analysis of the early events during repopulation of the thymus by the bone marrow prothymocyte. Cell. Immunol. 128:63-78.
71. Levy, J.A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183.
72. Lewis, D.D., C.C. Yu, and K.A. Forbush. 1991. J. Exp. Med. 173:89-100.
73. Lopez, M.C., L.L. Colombo, D.S. Huang, Y. Wang, and R.R. Watson. 1992. Modification of thymic cell subsets induced by long term cocaine administration during a murine retroviral infection producing AIDS. Clin. Immunol. Immonopathol. 65:45-52.
74. Maggi, E., D. Macchia, P. Parronchi, M. Mazzetti, A. Ravina, D. Milo, and S. Romagnani. 1987. Reduced production of interleukin 2 and interferon-gamma and enhanced helper activity for IgG synthesis by cloned CD4+ T cells from patients with AIDS. Eur. J. Immunol. 17:1685-1690.
75. Makino, M., Y. Sei, P.K. Arora, H.C. Morse, III, and J.W. Hartley. 1993. Impaired calcium mobilization in CD4+ and CD8+ T cells in a retrovirus-induced immunodeficiency syndrome, murine AIDS. J. Immunol. 149:1707-1713.
76. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705.
77. Martinez-Maza, O., E. Grabb, R.T. Mitsuyasu, J.L. Fahley, and J.V. Giogi. 1987. Infection with the human immunodeficiency virus (HIV) is associated with an in vitro increase in B lymphocyte activation and immaturity. J. Immunol. 138:3720.
78. McCune, J.M. 1991. HIV-1: The infective process in vivo. Cell 64:351.
79. Mellors, J.W., B.P. Griffith, M.A. Ortiz, M.A. Landry, and J.L. Ryan. 1991. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163:78-82.
80. Meltzer, M.S. et al. 1990. Macrophages and the human immunodeficiency virus. Immunol. Today 11:217.
81. Meyaard, I., H. Schuitemaker, and F. Miedema. 1993. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol. Today 14:161-164.
82. Miedema, F. 1992. Immunological abnormalities in the natural history of HIV infection mechanisms. Immunol. Rev. 3:173.
83. Morse, H.C. III, R.A. Yetter, and G.M. Sherer. 1988. Murine model of immunosuppression in relationship to AIDS. pp. 22-27. In HTLV I, II, III and related diseases. (Ed. Gallo R) Martinez-Nijhoff.
84. Mosier, D.E. 1986. Animal models for retrovirus-induced immunodeficiency disease. Immunol. Invest. 15:233-261.
85. Mosier, D.E., R.A. Yetter, and H.C. Morse III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766-784.
86. Muralidhar, G., S. Koch, M. Haas, S.L. Swain. 1992. CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J. Exp. Med. 175:1589-1599.
87. Odeleye, O.E., C.D. Eskelson, S.I. Mufti, and R.R. Watson. 1992. Vitamin E protection against nitrosamine-induced esophageal tumor incidence in mice immunocompromised by retroviral infection. Carcinogenesis 13:1811-1816.
88. Oliff, A. 1988. The role of tumor necrosis factor (cachectin) in cachexia. Cell 54:141.
89. Pace, J.L., S.W. Russell, B.A. Torres, H.M. Hohnson, and P.W. Gray. 1983. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130:2011-2013.
90. Pahwa, S., R. Pahwa, C. Saxinger, R.C. Gallo, and R.A. Good. 1985. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc. Natl. Acad. Sci. (USA) 82:8198.
91. Paeck, R., R. Rubin, and P.A. Bauerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NK-kappaB transcription factor and HIV-I. EMBO J. 10:2247-2258.
92. Pantaleo, G.Q., et al. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
93. T. Petro, D.S. Huang, and R.R. Watson. 1993. Alcohol, cocaine, murine AIDS and resistance to Giardia. Adv. Biol. Sci. 86:315-323.
94. Plum, I., M. De Smedt, and G. Leclercq. 1990. Inhibitory effect of murine recombinant IL-4 on thymocyte development in fetal thymus organ cultures. J. Immunol. 145:1066-1073.
95. Poli, G., P. Bressler, and A. Kinter. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151-158.
96. Powrie, F., and R.L. Coffman. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today. 14:270-274.
97. Rieckmann, P., G. Poli, H. Fox, J.H. Kehrl, and A.S. Fauci. 1991. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production abd Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J. Immunol. 147:2922.
98. Rieckmann, P., G. Poli, J.H. Kehri, and A.S. Fauci. 1991. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J. Exp. Med. 173:1.
99. Romangani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12:256-257.
100. Roederer, M., F.I. Stall, P.A. Raju, S.W. Ela, and I.A. Herzenberg. 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. (USA) 87:4884-4888.
101. Rosenberg, Z.F., and A.S. Fauci. 1989. The immunopathogenesis of HIV infection. Adv. Immunol. 47:377.
102. Saltman, P. 1989. Oxidative stress: a radical view. [Review]. Semin. Hematol. 26:249-256.
103. Schuurman, H.J., W.J.A. Krone, R. Broekhuizen, J. Van Baarlen, P. Van Veen, A.L. Goldstein, J. Huber, and J. Goudsmit. 1991. The thymus in acquired immune deficiency syndrome. Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. Am. J. Pathol. 134:1329-1338.
104. Scollay, R., A. Wilson, A. D'aico, K. Kelly, M. Egreton, M. Pearse, I. Wu, and M. Shormamn. 1988. Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol. Rev. 104:81-120.
105. Sher, A., R.T. Gazzinelli, I.P. Oswald, M. Clerici, M. Kullberg, E.J. Pearce, J.A. Berzofsky, T.R. Mosmann, S.L. James, H.C. Morse III, G.M. Shearer. 1992. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183-204.
106. Shnittman, S.M., K.H. Singer, J.J. Greenhouse, S.K. Stanley, I.P. Whichard, B.F. Haynes, and A.S. Fauci. 1991. Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. J. Immunol. 147:2553-2558.
107. Schnittman, S.M., K.H. Singer, J.J. Greenhouse, S.K. Stanley, I.P. Whichard, H.F. Haynes, and A.S. Fauci. 1991. VII International Conference on AIDS. Abstract Book Vol 2 Florence, Italy, p. 153.
108. Soave, R. 1988. Cryptosporidiosis in AIDS. Pp. 713-735. In AIDS and Other Manifestations of HIV Infection. Noyes Publications.
109. Stall, F.J.T., M. Roederer, and I.A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor Kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. (USA) 87:9943-9947.
110. Suthanthiran, M., M.E. Anderson, V.K. Sharma, and A. Meister. 1990. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. (USA) 87:3343-3347.
111. Tanaka, K.E., W.C. Hatch, Y. Kress, R. Soeiro, T. Calvelli, W.K. Rashbaum, A. Rubinstein, and W.D. Lyman. 1992. HIV-1 infection of human fetal thymocytes. J. AIDS 5:94-101.
112. Tepper, R.I., D.A. Levinson, and B.Z. Stanger. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62:457-467.
113. Toledano, M., and W. Leonard. 1991. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. (USA) 88:4328-4332.
114. Wang, Y., D.S. Huang, P.T. Giger, and R.R. Watson. 1993. The kinetics of imbalanced cytokine production by T cells and macrophages during the murine AIDS. Adv. Biosci. 86:335-340.
115. Wang, Y., D.S. Huang, P.T. Giger, S. Wood, R.R. Watson. 1995. Kinetics of cytokine production by thymocytes during murine AIDS caused by LP-BM5 retrovirus infection. Immunol. Letter 47:187-192.
116. Watson R.R., 1989. In Cofactors in HIV-I Infection and AIDS. CRC Press, pp. 47-54.
117. Weiss, R.A. 1993. How does HIV cause AIDS? Science 260:1273-1279.
118. Weiss, R.A. 1993. In The Retroviridae (Ed. Levy JA). Plenum, New York, pp. 1-108.
119. World Health Organization. The HIV/AIDS Pandemic: 1993 Overview (document WHO.GPA/CNP/EVA/93.1 Global Program on AIDS, Geneva, 1993.
120. Yarchoan, R., R.R. Redifield, S. Broder. 1986. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J. Clin. Invest. 78:439.
121. Yetter, R.A., R.M. Buller, J.S. Lee, K.L. Elkins, D.E. Mosier, T.N. Fredrickson, and H.C. Morse III. 1988. CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:623-635.
122. Yokota, T., R.L. Coffman, and H. Hagiwara. 1987. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5. Proc. Natl. Acad. Sci. (USA) 84:7388-7392.